1. Home
  2. KALV vs BZH Comparison

KALV vs BZH Comparison

Compare KALV & BZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$15.75

Market Cap

757.7M

Sector

Health Care

ML Signal

HOLD

Logo Beazer Homes USA Inc.

BZH

Beazer Homes USA Inc.

HOLD

Current Price

$20.09

Market Cap

672.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
BZH
Founded
N/A
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
757.7M
672.0M
IPO Year
2014
1995

Fundamental Metrics

Financial Performance
Metric
KALV
BZH
Price
$15.75
$20.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$30.00
$32.00
AVG Volume (30 Days)
721.4K
355.7K
Earning Date
03-25-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,000,000.00
$2,087,739,000.00
Revenue This Year
N/A
$4.36
Revenue Next Year
N/A
$10.79
P/E Ratio
N/A
N/A
Revenue Growth
495.66
N/A
52 Week Low
$9.83
$17.37
52 Week High
$19.00
$28.33

Technical Indicators

Market Signals
Indicator
KALV
BZH
Relative Strength Index (RSI) 45.58 24.38
Support Level $14.59 $19.90
Resistance Level $16.49 $24.10
Average True Range (ATR) 0.98 0.72
MACD -0.06 -0.42
Stochastic Oscillator 13.35 0.00

Price Performance

Historical Comparison
KALV
BZH

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in states and metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the sources of revenue for the company. Its segments involve: West segment that includes Arizona, California, Nevada, and Texas; East segment that includes Delaware, Indiana, Maryland, Tennessee, and Virginia; and Southeast segment which includes Florida, Georgia, North Carolina, and South Carolina.

Share on Social Networks: